The rehabilitation of thalidomide.
MacDougall
D S
DS
D000014:Abnormalities, Drug-Induced; D018791:CD4 Lymphocyte Count; D016265:Conflict of Interest; D003267:Contraception; D017277:Drug Approval; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology; D019247:HIV Wasting Syndrome / Q000188:drug therapy*; D006801:Humans; D010523:Peripheral Nervous System Diseases / Q000188:drug therapy; D011247:Pregnancy; D013723:Teratogens; D013792:Thalidomide / Q000009:adverse effects / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration; D019562:Viral Load
D013723:Teratogens; D013792:Thalidomide